$USAQ focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through the use of emerging digital and point of care technologies, is proud to announce the newest digital medicine and point of care clinical decision-making tools that will be brought into the market throughout 2022. The company's flagship product, QHSLab, is a clinical decision support system combining intelligent patient health risk assessments with medical guideline-based care coordination recommendations for medical providers at the point of care and in non-face-to-face settings. QHSLab was designed to address high-cost acuity and chronic health conditions with low-cost interventions that reimburse busy primary care physicians.https://finance.yahoo.com/news/qhslab-expands-digital-prescription-product-130000878.html